主要语言与炎症性肠病治疗和结果的关联
Laura C Sahyoun1, Veronica Chavez2, Jaya Vasudevan2
1Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, New York, USA.
Clinical and translational gastroenterology
|June 6, 2025
概括
在炎症性肠病 (IBD) 患者中,语言障碍不会显著影响先进治疗 (AT) 的使用或疾病活性. 需要进一步的研究来探索语言对坚持和患者理解的影响.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 炎症性肠病 (IBD) 的患病率在非英语人口中正在增加.
- 了解语言障碍和文化差异对于有效的IBD管理至关重要.
研究的目的:
- 研究初级语言对IBD患者先进治疗 (AT) 使用和疾病活性的影响.
- 为了比较英语和非英语IBD队列之间的AT利用率和临床缓解率.
主要方法:
- 一个多中心,回顾性,队列研究与1:2英语说话的对照进行了匹配.
- 成年IBD患者说非英语语言被跟踪了12个月.
- 先进疗法 (AT) 包括生物药物或小分子;评估结果是AT使用,启动和无皮质类固醇缓解.
主要成果:
- 分析了144名IBD患者 (48名非英语,96名英语使用者).
- 非英语说话者表现出较高的初值便calprotectin (91.7%对50%).
- 在调整后,在组之间没有观察到AT使用,启动或在6个月或12个月内无皮质类固醇缓解的显著差异.
结论:
- 在这项研究中,说的主要语言并没有显著影响AT使用或IBD疾病活性.
- 未来的研究应该检查语言在药物坚持,患者理解和满意度方面的作用.
- 需要进一步的研究才能充分理解语言对IBD长期结果的影响.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
432
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
432
Inflammatory Bowel Disease IV: Pharmacological Management
205
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
205
Drugs for Treatment of Ulcerative Colitis in IBD
244
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
244
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
212
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
212
Chronic Bowel Disorders: Introduction
544
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
544
Inflammatory Bowel Disease I: Ulcerative Colitis
348
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
348


